Page 2 - Liso Cel News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Liso cel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Liso Cel Today - Breaking & Trending Today
Alexey Danilov, MD, PhD, reviews data from the TRANSCEND NHL 001 study investigating lisocabtagene maraleucel in patients with relapsed/refractory mantle cell lymphoma. ....
The FDA has granted priority review to the supplemental biologics license application seeking approval to expand the indication of lisocabtagene maraleucel to include patients with chronic lymphocytic leukemia or small lymphocytic lymphoma who had prior exposure to a BTK inhibitor and a BCL-2 inhibitor. ....